Lerodalcibep can be a treatment option for patients requiring additional LDL-C reduction: GlobalData GlobalData Mar 4, 2025 Lerodalcibep is a novel therapy designed to lower low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic…
Alirocumab can address unmet needs in pediatric familial hypercholesterolemia: GlobalData EP News Bureau Feb 20, 2024 Praluent (alirocumab) is a monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9), an enzyme that…
Lupin launches authorised generic version of Antara in US EP News Bureau Nov 3, 2021 Fenofibrate Capsules are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total…
Novartis analysis shows inclisiran lowers LDL-C with high consistency EP News Bureau Aug 30, 2020 The analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies…